These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20546278)

  • 1. Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus.
    McKnight AJ; Pettigrew KA; Patterson CC; Kilner J; Sadlier DM; Maxwell AP;
    Diabet Med; 2010 Jun; 27(6):624-30. PubMed ID: 20546278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
    BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes.
    Craig DW; Millis MP; DiStefano JK
    Diabet Med; 2009 Nov; 26(11):1090-8. PubMed ID: 19929986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors in diabetic nephropathy.
    Freedman BI; Bostrom M; Daeihagh P; Bowden DW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1306-16. PubMed ID: 17942768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysis.
    McKnight AJ; Patterson CC; Sandholm N; Kilner J; Buckham TA; Parkkonen M; Forsblom C; Sadlier DM; Groop PH; Maxwell AP;
    Am J Nephrol; 2010; 32(5):476-81. PubMed ID: 20962522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.
    Patel A; Scott WR; Lympany PA; Rippin JD; Gill GV; Barnett AH; Bain SC;
    Diabet Med; 2005 Jan; 22(1):69-73. PubMed ID: 15606694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of bone morphogenetic protein-7 (BMP-7) and its type II receptor (BMP-RII) in kidney of type 1-like diabetic rats.
    Yeh CH; Chang CK; Cheng MF; Lin HJ; Cheng JT
    Horm Metab Res; 2009 Aug; 41(8):605-11. PubMed ID: 19440953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.
    Schön S; Prante C; Bahr C; Tarnow L; Kuhn J; Kleesiek K; Götting C
    Diabetes Care; 2006 Oct; 29(10):2295-9. PubMed ID: 17003309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
    Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
    J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
    Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM
    Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
    Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
    Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing genetic susceptibility to diabetic nephropathy.
    Tanaka N; Babazono T
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S17-21. PubMed ID: 16174281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
    Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
    J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening.
    Nair S; Phillips AO; Norton N; Spurlock G; Williams HJ; Craig KJ; Williams JD; Williams NM; Bowen T
    J Nephrol; 2008; 21(3):400-5. PubMed ID: 18587729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
    Bakker SJ; Alkhalaf A; Tarnow L; Navis G
    Diabetes; 2008 Dec; 57(12):e16; author reply e17. PubMed ID: 19033401
    [No Abstract]   [Full Text] [Related]  

  • 19. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of polymorphisms within the transforming growth factor-β1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations.
    Valladares-Salgado A; Angeles-Martínez J; Rosas M; García-Mena J; Utrera-Barillas D; Gómez-Díaz R; Escobedo-de la Peña J; Parra EJ; Cruz M
    Nephrology (Carlton); 2010 Sep; 15(6):644-8. PubMed ID: 20883286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.